CIP
NEO icon

Chartwell Investment Partners’s NeoGenomics NEO Stock Holding History

Chartwell Investment Partners’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-51,247
Closed -$710K – 430
2024
Q2 		$710K Sell
51,247
-8,336
-14% -$118K 0.02% 372
2024
Q1 		$937K Buy
59,583
+1,425
+2% +$22K 0.03% 368
2023
Q4 		$941K Sell
58,158
-7,852
-12% -$128K 0.03% 366
2023
Q3 		$812K Hold
66,010
– – 0.03% 365
2023
Q2 		$1.06M Sell
66,010
-17,087
-21% -$282K 0.04% 347
2023
Q1 		$1.45M Buy
+83,097
New +$1.18M 0.06% 313

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Chartwell Investment Partners's NEO Position: Q3 2024 in Review

Chartwell Investment Partners sold out of NeoGenomics (NEO) in Q3 2024, closing a stake of 51,247 shares — an estimated $710K sold.

Chartwell Investment Partners first reported a position in NEO in Q1 2023 and held it in 6 quarters. The position peaked at $1.45M in Q1 2023. 270 funds tracked by Wall St. Rank hold NEO as of Q3 2024.

  • Chartwell Investment Partners reported no remaining NeoGenomics position as of Q3 2024 after selling out during the quarter.
  • Chartwell Investment Partners sold 51,247 NeoGenomics shares in Q3 2024, an estimated $710K.
  • Chartwell Investment Partners first reported a position in NeoGenomics in Q1 2023 and held it in 6 quarters.
  • Chartwell Investment Partners's NeoGenomics position peaked at $1.45M in Q1 2023.
  • 270 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2024.

Based on Chartwell Investment Partners's 13F filing for Q3 2024, filed 4 Nov 2024.